AOD-9604 is a modified C-terminal fragment of hGH (residues 176u2013191). It retains the lipolytic and anti-lipogenic properties of full HGH while being free from growth-promoting effects and glucose intolerance. It activates u03b23-adrenergic receptors in adipose tissue to stimulate fat breakdown.
Overview
Reconstitution Table (2 mL mL BAC water u2192 5 mg)
| Dose | Draw (U-100) | Timing |
| 500 mcg | 2 Units | Fasted AM (preferred) |
| 1 mg | 4 Units | Fasted AM |
Reconstitute 5 mg with 2 mL BAC water u2192 2,500 mcg/mL. 1 mg = 4 Units. Administer subcutaneously. Best results with fasted injection.
AOD-9604 does not raise IGF-1 or affect glucose metabolism at standard doses. Longer safety profile than full HGH. Research use only.
Potential Benefits & Side Effects
Potential Benefits
- Lipolysis without IGF-1 elevation
- No effect on glucose metabolism
- Visceral and subcutaneous fat targeting
- Well-tolerated relative to full HGH
Possible Side Effects
- Mild injection-site reactions
- Headache (uncommon)
Storage Instructions
Lyophilized Powder
- Short-term (<3 months): Refrigerate at 2u00b0Cu20138u00b0C
- Long-term: Freeze at u221220u00b0C or lower
- Protect from light and moisture
- Allow vial to reach room temperature before opening
Reconstituted Solution
- Refrigerate at 2u00b0Cu20138u00b0C u2014 do not freeze
- Use within 28 days when reconstituted with BAC water
- Always use sterile technique when drawing doses
References
Important Note
This protocol guide is for educational and research purposes only. It is not medical advice. Always consult a qualified healthcare professional before using any peptide compound.